Diagnostics should not stop at the species boundary
Zoo and wildlife medicine rarely offers the luxury of a conventional patient.
A single clinical day may involve a reptile, bird, aquatic species, large mammal, or an animal for which species-specific diagnostic options are limited. Exposure histories can be uncertain, sample volumes may be precious, and the organisms involved may not be the ones clinicians initially expect.
MiDOG uses next-generation sequencing to analyze microbial DNA directly from veterinary samples and supports testing across animal species and a wide variety of sample types. Its All-in-One Test provides broad detection of bacterial, fungal, and parasitic organisms together with antimicrobial resistance information.
One sequencing approach. An extraordinary patient list.
At AAZV 2026, we are bringing the conversation directly to the clinicians, researchers, and animal-health professionals working with some of veterinary medicine’s most diverse patient populations.
Meet the MiDOG team to discuss how broad microbial sequencing can support the investigation of infectious disease when the patient is unusual, the differential list is wide, the sample is difficult to replace, or targeted testing does not adequately address the clinical question.
Talk to us about
- Zoo and wildlife infectious disease investigations.
- Avian, reptile, aquatic, and exotic animal samples.
- Difficult-to-culture or unexpected organisms.
- Mixed microbial findings and polymicrobial infections.
- Parasite detection using sequencing.
- Antimicrobial resistance information.
- Unusual sample types and limited diagnostic material.
- Population-health and research applications.
AAZV describes its community as veterinarians advancing the health and welfare of zoo animals and wildlife, while the annual conference brings together zoo veterinarians, researchers, and scientists working in wildlife health and conservation.
Bring Us the Unusual Case
From an individual patient to a population-level question, visit the MiDOG team in Oklahoma City to discuss the diagnostic challenge in front of you and see what next-generation sequencing can contribute.
